We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NWBI:NASDAQNorthwest Bancshares, Inc. Analysis

Data as of 2026-04-21 - not real-time

$13.36

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

NWBI is trading at $13.36, comfortably above its 20‑day SMA (13.08) and 50‑day SMA (12.79), while the 200‑day SMA sits at 12.49, confirming a bullish alignment. The RSI 60.6 and a bullish MACD histogram (+0.01) reinforce upward momentum, though the stock is approaching the 52‑week resistance of $13.75 with decreasing volume, suggesting limited short‑term upside. Volatility over the past 30 days is moderate at 15%, and a beta of 0.78 indicates lower sensitivity to market swings. Valuation metrics show a trailing P/E 14.5 versus the industry average of 17.7 and a forward P/E of 9.4, indicating the stock is priced fairly or slightly below peers. The dividend yield 5.98% is attractive, but a payout ratio of 87% raises questions about sustainability. The Fear & Greed Index at 86 reflects extreme market optimism, which could compress future upside.
Revenue surged 25% YoY, and operating margins are strong at 40%, delivering a profit margin of 21% and an ROE of 7.2%, underscoring solid earnings quality. Recent analyst commentary upgraded the stock to “Hold” after a strong Q4 2025 performance and improving asset quality, and the company will present Q1 2026 results on April 27, providing a catalyst for re‑evaluation. The DCF fair‑value estimate of $23.85 suggests considerable long‑term upside beyond the current price. However, free cash flow is currently zero, and the high dividend payout may limit cash flexibility. With a modest max drawdown of 16.5% and a stable regional footprint across four states, geographic and regulatory risks remain low to medium. Overall, the blend of bullish technicals, reasonable valuation, and strong dividend income makes NWBI a compelling candidate for investors with a medium‑ to long‑term horizon, provided they monitor dividend sustainability and upcoming earnings.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Near 52‑week resistance at $13.75
  • Decreasing volume signals waning momentum
  • Upcoming Q1 earnings may cause volatility

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Strong 25% revenue growth
  • Attractive 5.98% dividend yield
  • Fair valuation relative to peers (P/E 14.5 vs 17.7)

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • DCF fair value indicates upside
  • Stable regional presence across four states
  • Consistent dividend income despite high payout

Key Metrics & Analysis

Financial Health

Revenue Growth25.10%
Profit Margin21.03%
P/E Ratio14.5
ROE7.23%
ROA0.81%
P/B Ratio1.0
Op. Cash Flow$153.4M
Industry P/E17.7

Technical Analysis

TrendBullish
RSI60.6
Support$12.30
Resistance$13.75
MA 20$13.08
MA 50$12.79
MA 200$12.49
MACDBullish
VolumeDecreasing
Fear & Greed Index86.2

Valuation

Fair Value$23.85
Target Price$13.86
Upside/Downside3.76%
GradeFair
TypeBlend
Dividend Yield5.98%

Risk Assessment

Beta0.78
Volatility15.37%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.